Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel Agents

Plasma cell leukemia (PCL) is a rare and very aggressive plasma cell disorder. The optimal treatment approach, including whether to pursue an autologous (autoSCT) or allogeneic (alloSCT) transplant is not clear as there is lack of clinical trial based evidence. This single center retrospective study...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biol Blood Marrow Transplant
Egile Nagusiak: Lemieux, Christopher, Johnston, Laura J., Lowsky, Robert, Muffly, Lori S., Craig, Juliana K., Shiraz, Parveen, Rezvani, Andrew, Frank, Matthew J., Weng, Wen-Kai, Meyer, Everett, Shizuru, Judith, Arai, Sally, Negrin, Robert, Miklos, David B., Sidana, Surbhi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8083942/
https://ncbi.nlm.nih.gov/pubmed/32961371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.08.035
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak